AzTrials
AzTrials

Gambling DisorderNCT06467422

Effects of Transcranial Temporal Interference Stimulation on Risky Decision-making and Impulse Control in Gambling Disorder

A study testing tTIS on dACC, theta frequency (5 Hz) and tTIS on dACC, High frequency in people with Gambling Disorder, run by Shanghai Mental Health Center at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this research is to investigate the effect of transcranial temporal interference stimulation (tTIS) targeting the dorsal anterior cingulate cortex in patients with gambling disorder. Read more about this study

Who is it for?
Ages 18 to 60 years, men only
Conditions the study is for
Gambling Disorder
What is being tested?
tTIS on dACC, theta frequency (5 Hz) and tTIS on dACC, High frequency
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteChina
Study dates
20 Jun 2024to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged 18-60, male or female, right handed;
  • With 9 or more years of education, and able to cooperate in completing the questionnaire assessment and behavioural tests.
  • Meets the DSM-5 diagnostic criteria for gambling addiction;
  • Previous gambling behaviour of not less than 1 year's duration (at least one gambling session per week or more);
  • Normal or corrected normal vision and hearing;
  • Agrees to cooperate in completing the follow-up assessment;
Show all 9Show fewer
  • No history of neurological problems or head injury; and no skin sensitivity.
  • Agree to cooperate in completing the follow-up assessment;
  • No metal implantation in the head, no history of neurological problems or head injury, and no skin sensitivity.

Who cannot join

  • Suffering from severe cognitive dysfunction, such as a history of head trauma, cerebrovascular disease, epilepsy, etc., use of cognitive-promoting medications in the last 6 months;
  • Other psychoactive substance abuse or dependence in the last 5 years (except nicotine).

Trial locations and contacts

1 site in 1 country.

Tianzhen Chen, M.D, Ph.D contact

021-34773523

vomchan@hotmail.com

China1 site
  • Shanghai Mental Health Center

    Shanghai, Shanghai Municipality, 200000

    Min Zhao, M.D, Ph.D, 18017311005

Other trials in China

About this study

Official title: Exploring the Role and Neural Mechanisms of Transcranial Temporal Interference Stimulation Modulating the Dorsal Anterior Cingulate Cortex on Risky Decision-making and Impulse Control in Gambling Disorder

The purpose of this research is to investigate the effect of transcranial temporal interference stimulation (tTIS) targeting the dorsal anterior cingulate cortex in patients with gambling disorder.

Read the detailed description

This study will apply the emerging non-invasive deep brain stimulation of tTIS to the dorsal anterior cingulate cortex in a randomized, double-blind design to demonstrate the possibility of non-invasively targeting the anterior cingulate cortex to modulate impulse control and risky decision-making without activating other regions below the electrodes. Additionally, this study will combine the fMRI recordings to describe local and network effects on brain activity. Specifically, each participant will be assessed at baseline with a scale and T1WI sequence and diffusion tensor imaging, and will randomly receive a combination of stimulation sequentially during the intervention phase, with more than a one-week interval ensuring that there is no interference between each of the two stimulation sequences.

Being tested
tTIS on dACC, theta frequency (5 Hz), tTIS on dACC, High frequency
Medical subject headings
Gambling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tTIS on dACC, theta frequency (5 Hz)Device

    Device: Transcranial electric stimulation device

    The first pair of electrodes continuously outputs a current with a frequency of f1 = 2 kHz, while the second pair continuously outputs a current with a frequency of f2 = 2.006 kHz. According to the principle of time-domain coherence, an alternating electric field with a frequency of f2-f1 = 6 Hz can be generated in the target area. The experimental group receives a stimulation intensity of 2mA for 20 minutes. The optimal electrode position and current parameters are determined by using the MIDA head electric field model.

  • tTIS on dACC, High frequencyDevice

    The first pair of electrodes continuously outputs a current with a frequency of f1 = 2 kHz, while the second pair continuously outputs a current with a frequency of f2 = 2 kHz. The sham group receives a stimulation intensity of 2mA for 20 minutes. The optimal electrode position and current parameters are determined by using the MIDA head electric field model.

Study groups in NCT06467422
Study groupRoleWhat they receive
Theta Stimulation(6Hz, generated with electrodes of 2kHz and 2.005kHz)ExperimentalSession1#T1(10min)+DTI(15min) Session2#rsfMRI(8min)+rsfMRI-Theta tTIs(8min)+rsfMRI(8min)+TASK fMRI-Theta TI(20min)
Receives: Device: tTIS on dACC, theta frequency (5 Hz)
High Frequency Stimulation(generated with two electrodes of 2kHz)Sham comparatorSession1#T1(10min)+DTI(15min) Session2#rsfMRI(8min)+rsfMRI-HF tTIs(8min)+rsfMRI(8min)+TASK fMRI-HF TI(20min)
Receives: Device: tTIS on dACC, High frequency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Activation of dACC

    Activation of dACC is measured with resting-state fMRI and task fMRI.

    Measured: Through the fMRI procedure

  2. Activation of decision-making network

    Activation of decision-making network is measured with resting-state fMRI and task fMRI connectivity analysis.

    Measured: Through the fMRI procedure

  3. The change of impulsivity

    The change of impulsivity will be measured by sequential decision-making task.

    Measured: Through the last 20 minutes of the fMRI session.

Secondary outcomes (1)
  1. The change of gambling craving

    Gambling craving will be measured by the gambling craving Visual Analog Scale (VAS). The total score of VAS ranged from 0 to 10, in which higher scores mean a higher level of gambling craving.

    Measured: 8 minutes, 16 minutes, 24 minutes, 44 minutes of the fMRI session.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2024
  2. Study start20 Jun 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion1 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06467422
Sponsor's protocol ID
MZhao-017
Status last verified
Jun 2024
First submitted
6 Jun 2024
Last updated
21 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing tTIS on dACC, theta frequency (5 Hz) and tTIS on dACC, High frequency in people with Gambling Disorder, run by Shanghai Mental Health Center at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tianzhen Chen, M.D, Ph.D (021-34773523, vomchan@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Activation of dACC (time frame: Through the fMRI procedure). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in